Showing posts with label Drug-drug co-crystals. Show all posts
Showing posts with label Drug-drug co-crystals. Show all posts

Tuesday 19 August 2014

Drug-drug co-crystals.

Figure 1
Representation of drug-drug co-crystal and combination drug.
 
 
 
 
Active pharmaceutical ingredients (APIs) are most conveniently developed and delivered orally as solid dosage forms that contain a defined crystalline form of an API. Co-crystal is a crystalline entity formed by two different or more molecular entities where the intermolecular interactions are weak forces like hydrogen bonding and π-π stacking. Co-crystals are an enabling technology that is used in new or existing drug delivery systems by majority of pharmaceutical companies in formulation and drug development.
 
 read all at